Navigation Links
Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Date:8/27/2007

EDISON, N.J., Aug. 27 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") and Ipca Laboratories Ltd. ("Ipca") announced today that they have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the U.S. prescription drug market. Under the Agreement, Ipca shall develop and register selected products for U.S. ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch.

Commenting on the Agreement, Heritage President & CEO, Jeffrey Glazer, stated, "Our agreement with Ipca represents yet another important strategic partnership with an emerging, low cost developer and supplier of active ingredients and finished goods. These types of agreements enable Heritage to leverage our business model of strategic outsourcing to obtain a "virtually vertical" supply chain of quality generic products as we continue to expand our product offerings."

Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its U.S. label in 2006 and currently markets 3 products over 10 SKU's. The Company will continue to introduce its acquired multi-source generic product line during 2007-08 following its tradition of premier quality, value and service in generics.

Ipca Laboratories Ltd. is a fast growing fully integrated pharmaceutical company based in Mumbai, India engaged in the manufacturing and marketing of a range of pharmaceuticals with a thrust on international business. Ipca exports its Active Pharmaceutical Ingredients and Finished Dosages to over 110 countries across the globe, which contributed about 53% of the Company's total global income of $227mm in the financial year 2006-07. It has a strong focus on international business in the developed markets like Europe and North America.


'/>"/>
SOURCE Heritage Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. UW-Madison to receive $125M for bioenergy research center
3. WARF enters licensing agreements for stem cell products
4. Internet-enabled niche markets take center stage
5. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
6. TomoTherapy opens technical training center
7. Stem cell and regenerative medicine center to aid education and commerce
8. Mega-Metro Center may go beyond Chicago and Wisconsin
9. Software company enters health space with RFID solutions on hold
10. Former Fiserv exec to enter Business Hall of Fame
11. Berbee to expand at New Venture Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... -- Market Research Future published a half-cooked research report on Global Cancer ... a CAGR of 12% during the period 2016 to 2022. ... ... division without any control. These abnormal cells have the ability to ... can spread to other parts of the body through the blood ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... Noom Inc. , the leader ... offer fully Spanish behavior change programs that address ... prevention and healthy weight management programs  have ... interventions among Hispanic Americans who are at increased ... database, program-specific curriculum content and program features are ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of the North American Spine Society (NASS)1 demonstrate high fusion rates at ... cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The implantable ...
Breaking Biology Technology:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)...   Avanade is helping Williams Martini Racing, ... history, exploit biometric data in order to critically analyse ... competitive edge against their rivals after their impressive, record-breaking ... has worked with Williams during the 2016 season to ... rate, breathing rate, temperature and peak acceleration) for key ...
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
Breaking Biology News(10 mins):